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In Brief
The ChromATin approach combines
analysis of epigenetic modifications by
immunostaining, localization of specific
DNA sequences by FISH, and high-
resolution segregation of nuclear
compartments using advanced array
tomography (AT) imaging, producing a
high-resolution picture of chromatin
architecture in complex tissues such as
the brain.
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We present ChromATin, a quantitative high-resolu-
tion imaging approach for investigating chromatin
organization in complex tissues. This method com-
bines analysis of epigenetic modifications by immu-
nostaining, localization of specific DNA sequences
by FISH, and high-resolution segregation of nuclear
compartments using array tomography (AT) imaging.
We then apply this approach to examine how the
genome is organized in the mammalian brain using
female Rett syndrome mice, which are a mosaic of
normal and Mecp2-null cells. Side-by-side com-
parisons within the same field reveal distinct hetero-
chromatin territories in wild-type neurons that are
altered in Mecp2-null nuclei. Mutant neurons exhibit
increased chromatin compaction and a striking
redistribution of the H4K20me3 histone modification
into pericentromeric heterochromatin, a territory
occupied normally by MeCP2. These events are not
observed in every neuronal cell type, highlighting
ChromATin as a powerful in situ method for exam-
ining cell-type-specific differences in chromatin
architecture in complex tissues.
INTRODUCTION
The organization of chromatin within the nucleus plays an impor-
tant role in the regulation of gene expression (Bickmore and van
Steensel, 2013; Politz et al., 2013). Although high-throughput
sequencing strategies have revolutionized chromatin research
by enabling genome-wide analysis of chromatin interactions
(Dixon et al., 2012; Lieberman-Aiden et al., 2009), fluorescent
in situ hybridization (FISH) remains a powerful tool in studying
the organization of chromosomal territories (Cremer andCremer,
2010). New high-resolution imaging technologies promise to
advance our understanding of how chromatin is packaged in
the nucleus for appropriate gene expression (Ricci et al., 2015;
Smeets et al., 2014).
New methods for examining chromatin architecture are
needed. The two most widely used strategies, chromosome
conformation capture (C-method) and FISH, each have their
own strengths and weaknesses. Although C-methods offer
base pair resolution and, in the case of HiC, genome-wide anal-246 Cell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc.ysis of chromatin, this method is most often performed on
pooled cell populations, which might obscure cell-type-specific
differences that exist in complex tissues. On the other hand,
FISH is an ideal method for analysis of different cell types in tis-
sue, but probes are typically limited to a small number of genetic
loci. Interestingly, these methods are not always in agreement
with regard to chromatin organization. For example, analysis of
the HoxD locus in mutant embryonic stem cells shows an open
chromatin structure using FISH and a closed structure using
5C (Williamson et al., 2014). A potential source of these differ-
ences is that C-methods may involve fixation of relatively large,
cross-linked chromatin domains, detecting cytological co-local-
ization rather than direct molecular interaction (Belmont, 2014;
Gavrilov et al., 2013). Also, to associate C-method and FISH re-
sults with chromatin modifications requires a separate analysis
using different experimental conditions. For these reasons, we
sought to develop a quantitative, high-resolution imaging
method for investigating chromatin organization in complex tis-
sues. This method would combine analysis of epigenetic modifi-
cations by immunostaining, localization of specific DNA
sequences by FISH, and high-resolution segregation of nuclear
compartments using an advanced imaging technique. We have
adapted the array tomography (AT) imaging method for this
purpose.
AT is a high-resolution imaging method developed for the
reconstruction and analysis of neuronal circuitry in the brain (Mi-
cheva and Smith, 2007). The enhanced resolution is achieved by
generating ultrathin serial sections of the specimen, followed by
image acquisition and alignment. Acrylic sections can be strip-
ped repeatedly, allowing for multiple rounds of imaging. This
multiplexed staining approach increases the amount of molecu-
lar information that can be derived from a tissue volume (Micheva
et al., 2010). FISH methods have not been reported for AT, and
developing this capability would increase the utility of the
approach for localizing DNA sequences or expressed RNAs.
Our motivation in developing this method was to gain a deeper
understanding of how the genome is organized in the mamma-
lian brain, a tissue with an extreme variety of cell types. To this
end, we tested AT for examining neuronal chromatin in mice
lacking the DNA binding protein, MeCP2. Mutations in MECP2
give rise to the neurological disorder, Rett syndrome (RTT)
(Amir et al., 1999). MeCP2 is expressed to high levels in neurons
and binds globally to methyl- and hydroxymethyl-cytosine within
different dinucleotide contexts (Guo et al., 2014; Lewis et al.,
1992; Melle´n et al., 2012). Mecp2 is an X-linked gene (Quaderi
et al., 1994), and cells in female RTT patients and mouse models
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Figure 1. Quantitative Analysis of Chro-
matin Architecture in Hippocampal Pyrami-
dal Neurons
(A) DAPI-stained nuclei in a 200 nm hippocampal
section from a symptomatic female RTT mouse
(Mecp2-EGFPB./+). The image was stitched from
multiple fields acquired using a 253 objective.
Scale bar, 100 mm. The white rectangle encloses
the portion of the CA1 pyramidal cell layer used for
high-resolution imaging.
(B) Volume rendering of 59 serial sections (200 nm
thick) through the hippocampal pyramidal cell
layer. DAPI labels nuclei, and an antibody to GFP
was used to identify cells expressingMeCP2-GFP.
Note mosaic expression of Mecp2-EGFP gene
due to random Xi. Scale bar, 10 mm.
(C–F) Nucleus from a WT pyramidal neuron.
(C) Volume rendering of the nucleus viewed along
the x-y axis. Scale bar, 1 mm. (D) Nucleus viewed
along the y-z axis. (E) 3D surfaces (red) used to
isolate heterochromatin for quantification. (F) A
single 3D surface (blue) encloses the entire con-
tents of the nucleus.
(G–I) Analysis of WT and Mecp2-null pyramidal
neurons.
(G) Scatterplot showing the percentage of total
nuclear DAPI pixel intensity located within the
heterochromatin threshold (mean ± SD). (WT,
22.5 ± 2.5%, n = 51 nuclei from three mice), (null,
27.1 ± 2.2%, n = 55 nuclei from three mice). Un-
paired t test, p < 0.0001. Xi chromosome values
were subtracted from total heterochromatin.
(H) Scatterplot showing the density of DAPI pixel
intensity within the heterochromatin threshold
(mean ± SD). Density is expressed as pixel intensity (3103) per mm3. WT, 50.7 ± 2.8; null, 54.4 ± 2.9. Unpaired t test, p < 0.0001.
(I) Scatterplot showing heterochromatin volume (mean ± SD). WT, 8.0 ± 1.0 mm3; null, 9.0 ± 0.9 mm3. Unpaired t test, p < 0.0001.
See also Figure S1 and Movie S1.are mosaic for loss of MeCP2 due to dosage compensation in
mammals (Adler et al., 1995). This mosaicism provides an ideal
experimental context wherein neurons with normal chromatin ar-
chitecture are adjacent to Mecp2-null neurons. While in vitro
studies suggest that MeCP2 may regulate higher-order chro-
matin structure, it is not known how these findings impact chro-
matin organization in vivo. Further, several additional models for
its function, including gene repression and activation, have also
been proposed (Lyst and Bird, 2015).
Using AT imaging, we quantify large-scale chromatin changes
in symptomatic adult female RTT mouse brain. We detect a sig-
nificant increase in chromatin compaction in two types of
Mecp2-null hippocampal neurons together with a striking redis-
tribution of the H4K20me3 histone modification into pericentro-
meric heterochromatin. In contrast, we do not detect these
changes in cerebellar granule cells. We observe a spectrum of
chromatin condensation states among cells in the nervous sys-
tem providing a potential mechanism to explain cell-type-spe-
cific differences in gene expression upon loss of MeCP2.
In summary, we show that AT is an ideal tool for investigating
chromatin architecture in complex tissues where cellular hetero-
geneity may confoundmethods that sample populations of cells.
Multiplexed detection of epigenetic modifications and genomic
sequences combines with the resolving power of the AT imagingmethod to permit quantitative analysis within defined nuclear
compartments.
RESULTS
Quantitative Analysis of Chromatin Organization
in Neurons Using AT
We initially chose hippocampal CA1 pyramidal neurons for our
investigation due to their location within a well-defined layer in
the hippocampus (Figure 1A). Neuronal nuclei, as in other cell
types, can be visualized using the fluorescent DNA intercalator,
DAPI (Wilson et al., 1990). To determine the utility of AT for
analyzing chromatin architecture, we exploited the mosaic
nature of female RTT mouse brain expressing a knockin Mecp2-
EGFPgene fusion (Lyst et al., 2013).Mosaicism is ideal for imaging
comparisons because fixation, embedding, staining, and imaging
stepsare equivalent for thewild-type (WT)andmutantpopulations
of neurons under investigation. As predicted, due to the X-linked
nature of Mecp2 and random X inactivation, the ratio of WT
(GFP positive) to mutant cells was approximately 1:1 (Figure 1B).
We found that 200 nm sections allowed for full-volume recon-
struction of an sufficient number of nuclei for analysis. Figure 1C
shows 3D reconstruction for a WT nucleus visualized along
the x-y axis, while Figure 1D shows equivalent resolution alongCell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc. 247
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Figure 2. Multiplexed Immunostaining for Histone Modifications
(A–I) Panels (A)–(I) represent fluorescence images acquired using the same
200 nm section through the hippocampal pyramidal cell layer.
(A) DAPI staining of CA1 pyramidal neuron nuclei. Right, two WT nuclei (see I).
Left, two mutant nuclei. Scale bar, 2 mm.
(B) Binding of the lectin Concanavalin A (ConA) to membrane glycoproteins.
(C) Merge of ConA (red) with DAPI (green).
(D) Immunostaining for H3K9me2.
(E) Immunostaining for H3K9me3.
(F) Immunostaining for H3K27me3. The two intense H3K27me3 clusters
represent the Xi. These clusters are not visible in the two lower nuclei because
this image is of a single 200 nm section.
(G) Immunostaining for H4K20me2.
(H) Immunostaining for H4K20me3.
(I) Immunostaining for the MeCP2-GFP fusion protein.
(J) DAPI staining of a nucleus from a WT neuron. Panels (J)–(L) represent
fluorescence images acquired from the same 200 nm section from another
mouse. Scale bar, 1 mm.
(K) Heatmap representation of DAPI pixel intensity for the section shown in
Figure 2J. The two adjacent heterochromatin clusters exhibit different density
profiles. Bar shows heatmap index.
248 Cell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc.the z axis. Heterochromatic foci in neuronal nuclei exhibit a
wide range of sizes and numbers. We therefore established a
threshold based upon pixel intensity to quantify heterochromatin
intensity and volume. A representative surface rendering of the
heterochromatic foci enclosed by our threshold is shown in Fig-
ure 1E. A second 3D surface enclosing the entire nucleus was
used to determine total nuclear volume and DAPI pixel intensity
(Figure 1F). The structures enclosed by these surfaces are best
visualized in Movie S1.
Using AT, we found that the total amount of nuclear DAPI did
not differ between WT and Mecp2-null neurons (Figure S1A).
However, loss of MeCP2 resulted in a 20% increase in the
amount of DNA packaged within the heterochromatin threshold
(Figure 1G). The increase in chromatin compaction was detected
as both an increase in DAPI density within heterochromatin (Fig-
ure 1H), as well as an increase in heterochromatin volume (Fig-
ure 1I). These results indicate that, inMecp2-null neurons, there
is a redistribution of DAPI-labeled DNA into more densely
compact heterochromatin, and the increase in volume is not
due to ‘‘unraveling’’ of chromatin within heterochromatic foci.
Previous studies found that nuclear diameters in RTT neurons
were smaller than WT neurons (Li et al., 2013; Stuss et al., 2013;
Yazdani et al., 2012). In agreement with these reports, AT anal-
ysis of nuclear volume revealed a modest (5%) decrease in
mutant neurons compared to WT (Figure S1B). Interestingly,
we found a strong negative correlation when we plotted hetero-
chromatin content versus nuclear volume for CA1 pyramidal
neurons regardless ofMeCP2 status (Figure S1C). This is consis-
tent with previous reports that show an expansion of nuclear size
when chromatin is decondensed (Mazumder et al., 2008; Shen
et al., 1995).
Resolving Spatial Organization of Histone Modifications
with Multiplexed Immunostaining
The other notable advantage of AT over other imaging methods
is the ability to perform multiple rounds of imaging on the same
sections using a variety of detection reagents. The observation
of more compact chromatin in Mecp2-null neurons led us to
examine whether we could detect any changes in heterochro-
matin-associated histone modifications. In Figure 2, we show
the results of multiplexed immunostaining using antibodies
against five different histone modifications, as well as for DAPI,
MeCP2-GFP, and Conconavalin A (ConA). Immunostaining for
H3K9me2, H3K9me3, H3K27me3, and H4K20me3 shows ex-
pected patterns in terms of their association with DAPI-labeled
heterochromatin, indicating that our cytological criterion for het-
erochromatin is consistent with previously published studies
(Figures 2D–2H).(L) Merged immunostaining for MeCP2-GFP (green) and H3K27me3 (red).
MeCP2-GFP is enriched in the heterochromatin cluster with higher DAPI pixel
intensity in Figure 2K, while H3K27me3 enriched heterochromatin has lower
DAPI pixel intensity.
(M) Scatterplot showing Xi DAPI pixel density (mean ± SD). Density is ex-
pressed as pixel intensity (3103) per mm3. WT, 42.0 ± 2.5, n = 51; null, 43.0 ±
3.3, n = 55. Unpaired t test, p = 0.078.
(N) Scatterplot showing the percentage of MeCP2-GFP (mean ± SD) localized
within the heterochromatin threshold in WT neurons. 30.4 ± 3.3%, n = 51.
See also Movie S2.
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Figure 3. The H4K20me3 Modification Is Redistributed Spatially
upon Loss of MeCP2
(A–F) Panels (A)–(F) represent fluorescence images acquired using the same
200 nm section through the hippocampal pyramidal cell layer.
(A) DAPI staining. Scale bar, 1 mm.
(B) Relative pixel intensity of DAPI staining. Heat map index is located in the
lower right corner. Arrow indicates lower intensity heterochromatin still within
threshold value. Arrowhead points to high intensity heterochromatin.
(C) Immunostaining forMeCP2-GFP.Left,WTnucleus; right,Mecp2-null nucleus.
(D) Immunostaining for H4K20me3. Arrows and arrowhead as in Figure 3B.
(E) Immunostaining for H4K20me2.
(F) Merged image for MeCP2-GFP and H4K20me3. In the WT nucleus,
MeCP2-GFP binding dominates in pericentromeric heterochromatin (arrow-
head), while H4K20me3 localizes to the heterochromatin region with lower
DAPI density (arrow).
(G) Scatterplot showing percentage of total nuclear H4K20me3 within het-
erochromatin in pyramidal neurons (mean ± SD). There is a significant redis-
tribution of H4K20me3 into heterochromatin after loss of MeCP2 (WT, 18.5 ±
3.0, n = 36 nuclei from three mice; null, 30.5 ± 3.5, n = 41 nuclei from three
mice). Unpaired t test, p < 0.0001.
(H) Scatterplot showing the percentage of total nuclear H4K20me2 within hetero-
chromatin (mean ± SD) for pyramidal neurons. WT, 10.8 ± 2.1, n = 27 nuclei from
two mice; null, 11.0 ± 2.2, n = 31 nuclei from two mice. Unpaired t test, p = 0.72.
See also Figures S2 and S3 and Movie S3.We always observed a single intense cluster of H3K27me3 in
female cells that represents the Xi (Figure 2F), and MeCP2-
GFP was generally excluded from this heterochromatin
compartment (Figures 2J–2L). These exclusive heterochromatin
territories are best appreciated by viewing the full 3D reconstruc-
tion (Movie S2). Using H3K27me3 immunostaining as a guide,
we isolated this compartment (green surface in Movie S1) from
total heterochromatin. Consistent with the observation that
MeCP2 is excluded from this territory, we did not observe a sig-
nificant difference in DAPI density for the Xi chromosome be-
tween WT and mutant neurons (Figure 2M). Further, the density
of DAPI within the Xi was less than the density within other het-
erochromatin compartments (80%, compare with Figure 1H).
This less condensed heterochromatin state for Xi has been
described previously by light and electron microscopy (Rego
et al., 2008).
In addition to quantifying DAPI intensity, the established het-
erochromatin threshold can be applied to all the imaging chan-
nels acquired in an experiment. For example, although it appears
upon visual examination that most of the MeCP2 is localized to
heterochromatic foci, low-intensity clusters are highly abundant
in euchromatin and nucleoplasm, resulting in heterochromatin
MeCP2 content being 30% of total MeCP2 in a pyramidal
cell nucleus (Figure 2N).
The H4K20me3 Modification Defines a Unique
Heterochromatin Territory
AT imaging revealed an unexpected alteration in the spatial orga-
nization of H4K20me3 when WT and Mecp2-null nuclei were
compared. In neurons deficient for MeCP2, H4K20me3 dis-
played a staining pattern that was almost identical to that of
DAPI (compare Figures 3A–3D, right nuclei), which is consistent
with previous reports that H4K20me3 is associated with pericen-
tromeric heterochromatin (Schotta et al., 2004). Strikingly, this
extensive overlap with heterochromatic foci was not observed
in WT neurons (Figures 3A–3D, left nuclei). In WT neurons,
MeCP2 clustered intensely in heterochromatic foci, while the
H4K20me3 intensity was reduced in these regions (arrowheads,
compare Figures 3D and 3F left nuclei), instead occupying a ter-
ritory peripheral to the dense heterochromatic foci (arrows, Fig-
ures 3D and 3F). These H4K20me3-rich territories are well within
the heterochromatin threshold, but they display reduced DAPI
intensity when compared to pericentromeric heterochromatin
(arrow, Figure 3B). The segregation of H4K20me3, H3K27me3,
and MeCP2 enriched heterochromatin territories is easily
observed using AT (Movie S3). We performed confocal micro-
scopy on brain sections to confirm that the H4K20me3 territories
were not an artifact of the AT procedure. Examination of CA1 py-
ramidal neurons from female heterozygotes or wild-type (WT)
male mice shows that the H4K20me3 territories can be detected
using standard microscopy methods albeit at lower resolution
(Figure S2).
We used the heterochromatin threshold to quantify the extent
of this altered localization and detected a robust (65%) redistri-
bution of H4K20me3 into dense heterochromatin upon loss of
MeCP2 (Figure 3G). This spatial redistribution occurred in
conjunction with a modest (11%) increase in the total nuclear
amount of H4K20me3 (see Figure 4F). In contrast toCell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc. 249
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Figure 4. TheH4K20me3Modification Expands into Pericentromeric
Heterochromatin in Mecp2-Null Nuclei
(A–D) Panels (A)–(D) represent fluorescence images taken from a volume
rendering through the hippocampal pyramidal cell layer.
(A) DAPI staining. Scale bar, 1 mm.
(B) Immunostaining for MeCP2-GFP identifies left neuron as WT and right
neuron as Mecp2 null.
(C) Immunostaining for H4K20me3.
(D) Merged image showing H4K20me3 distribution (red) relative to major
satellite FISH signal (green). In the WT neuron, H4K20me3-enriched regions
are peripheral to the major satellite heterochromatin territory.
(E) Scatterplot showing the percentage of total nuclear H4K20me3 within the
major satellite threshold (mean ± SD). There is a significant redistribution of
H4K20me3 into pericentromeric heterochromatin after loss of MeCP2 (WT,
11.8 ± 1.8, n = 19 nuclei from 3 mice; null, 23.7 ± 4.4, n = 19 nuclei from three
mice). Unpaired t test, p < 0.0001.
(F) The relative amount of H4K20me3 within the nucleus (mean ± SD) is
compared between WT and null neurons. Intensity units represent total inte-
grated intensity (3106) with mean intensity normalized for WT pyramidal
neurons. (WT, 1.00 ± 0.01, n = 46 nuclei from three mice; null, 1.11 ± 0.02, n =
50 nuclei from three mice. Unpaired t test, p < 0.0001.
See also Movie S4.H4K20me3, we did not observe a significant change in the
spatial organization of H4K20me2 with loss of MeCP2 (Fig-
ure 3H), indicating specificity in spatial organization of different
histone marks in mutant nuclei.
We also examined the spatial distribution of H3K9me3,
another heterochromatin-associated histone modification. Un-
like the case for H4K20me3, no heterochromatin territories
were enriched exclusively for this modification. In fact,
H3K9me3 appeared to be present throughout all of the hetero-
chromatin territories that we observed. Although it was difficult
to detect by eye, AT analysis showed that there was still a signif-250 Cell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc.icant (26%) redistribution of H3K9me3 into densely packed het-
erochromatin inMecp2-null nuclei (Figure S3A). This occurred in
conjunction with a 10% increase in total nuclear H3K9me3 levels
(Figure S3C). We also detected a slight redistribution of
H3K9me2 into dense heterochromatin (Figure S3B).
AT FISH Shows Expansion of the H4K20me3
Modification into Pericentromeric Heterochromatin in
Mecp2-Null Nuclei
Tomap chromosomal territoriesmore precisely in the nucleus, we
used peptide nucleic acid probes specific for both major and mi-
nor satellite sequences to localize pericentromeric and centro-
meric heterochromatin, respectively (Movie S4). We performed
one roundof immunostaining followedbyFISHon thesamehippo-
campal sections to determine the relative positions of H4K20me3,
MeCP2-GFP, and the major and minor satellite sequences. As
expected, the major satellite probe localized with the most
condensed heterochromatic foci (Figures 4A and 4D). As pre-
dicted on the basis of our DAPI staining, the H4K20me3-rich
territory was adjacent to the major satellite territory in WT nuclei
(Figure 4D, left nuclei). In neurons lackingMeCP2, this segregation
was lost, and H4K20me3 was enriched significantly in the major
satellite territory (Figure 4D, right nuclei). We created a 3D
threshold surrounding the major satellite FISH signal and
measured the intensity of H4K20me3 immunostaining within the
major satellite zone relative to the total nuclear intensity. We de-
tected a robust (100%) redistribution of H4K20me3 into pericen-
tromeric heterochromatin upon loss of MeCP2 (Figure 4E). This
spatial reorganization occurred in conjunction with a modest in-
crease in the total nuclear amount of the modification (Figure 4F).
Changes in Chromatin Architecture upon Loss
of MeCP2 Are Cell-Type Specific
To determine if the changes in chromatin architecture we
observed for CA1 pyramidal neurons were occurring in other
neuronal cell types, we performed a similar analysis for hippo-
campal dentate granule cells, as well as cerebellar granule cells.
We performed two rounds of antibody staining to collect infor-
mation for both H4K20me3 and H3K9me3 modifications, fol-
lowed by FISH for major satellite sequences. MeCP2-GFP is
abundant in dentate granule cell nuclei, with the typical strong
localization in heterochromatic foci (Figure 5B). Similar to CA1
pyramidal neurons, we find that loss of MeCP2 results in a signif-
icant redistribution (93%) of H4K20me3 into the major satellite
territory (Figures 5D and 5E). Analysis for H3K9me3 showed
redistribution to a lesser extent (37%, Figures S4E and S4G),
while H3K9me2 levels show a slight decrease in the major satel-
lite territory (Figures S4F and S4H). The changes in H4K20me3
and H3K9me3 in dentate granule cells lacking MeCP2 are
accompanied by a 15% increase in DAPI-labeled DNA pack-
aged into densely packed heterochromatin (Figure 5F).
We next imaged chromatin organization inWT andMecp2-null
cerebellar granule cells, which have smaller nuclei and abundant
heterochromatin. While we could easily identify MeCP2-positive
granule cells (Figure 5H), the expression level of MeCP2-GFP
and intensity in the major satellite territory was lower in these
neurons compared to other neuronal cell types. We could not
detect a change in the spatial distribution of H4K20me3 in
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Figure 5. H4K20me3 Redistribution in Mecp2-Null Nuclei Is a Cell-Type-Specific Event
(A–D) Panels (A)–(D) represent fluorescence images taken from a volume rendering through the suprapyramidal dentate granule cell layer.
(A) DAPI staining. Scale bar, 1 mm.
(B) Immunostaining for MeCP2-GFP identifies left neuron as WT and right neuron as Mecp2-null.
(C) Immunostaining for H4K20me3.
(D) Merged image showing H4K20me3 distribution (red) relative to major satellite FISH signal (green).
(E) Scatterplot showing the percentage of total nuclear H4K20me3 within the major satellite threshold (mean ± SD). There is a significant redistribution of
H4K20me3 into pericentromeric heterochromatin after loss of MeCP2 (WT, 14.0 ± 1.8, n = 15 nuclei from two mice; null, 27.0 ± 2.1, n = 15 nuclei from two mice).
Unpaired t test, p < 0.0001.
(F) Scatterplot showing the percentage of total nuclear DAPI pixel intensity located within the heterochromatin threshold (mean ± SD). WT, 24.7 ± 2.7; null, 28.5 ±
1.8. Unpaired t test, p < 0.0001. Panels (G)–(J) represent fluorescence images taken from a volume rendering through the cerebellar granule cell layer.
(G) DAPI staining. Scale bar, 1 mm.
(H) Immunostaining for MeCP2-GFP distinguishes between WT and Mecp2-null granule cells.
(I) Immunostaining for H4K20me3.
(J) Merged image showing H4K20me3 distribution (red) relative to major satellite FISH signal (green).
(K) Scatterplot showing the percentage of total nuclear H4K20me3 within the major satellite threshold (mean ± SD). WT, 30.7 ± 2.1, n = 17 nuclei from two mice;
null, 31.2 ± 1.8, n = 17 nuclei from two mice. Unpaired t test, p = 0.4075.
(L) Scatterplot showing the percentage of total nuclear DAPI pixel intensity located within the heterochromatin threshold (mean ± SD). WT, 56.2 ± 2.5; null, 56.9 ±
3.0. Unpaired t test, p = 0.4526.
See also Figures S4 and S5 and Movie S5.cerebellar granule cells (Figure 5K). Consistent with their visible
heterochromatic abundance, the amount of DAPI within hetero-
chromatin was much greater for these neurons than for the hip-
pocampal cell types we examined (Figure 5L). This was not a
consequence of the brain region per se because neighboring
cell types in the cerebellum expressed much higher levels of
MeCP2-GFP than granule cells and exhibited the alterations in
H4K20me3 organization that we observed for Mecp2-null hip-
pocampal neurons. For example, cerebellar Purkinje neurons
have extremely decondensed chromatin, and major satellite
repeats are typically packaged in a massive heterochromatin
cluster near the nucleolus (Figure S5A). In WT Purkinje neurons,
MeCP2-GFP clusters intensely in themajor satellite territory, andH4K20me3 is predominantly localized to an adjacent hetero-
chromatin territory (Figure S5B). In a Purkinje neuron that lacks
MeCP2, H4K20me3 spreads into themajor satellite territory (Fig-
ure S5C and Movie S5). Due to the large size of Purkinje nuclei,
we have not acquired enough data from full Purkinje nuclei to
quantify this change.
AT Analysis of Transcriptional Activity
We used antibodies against phosphorylated Serine5 on the car-
boxy terminal domain (CTD) of RNA polymerase II (RNAPII) to
quantify transcriptional activitywithinsinglenuclei (Egloff andMur-
phy, 2008). As predicted, the signal for this antibodywas excluded
from highly condensed heterochromatin (Figures 6A–6C). Further,Cell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc. 251
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Figure 6. AT Analysis of Transcriptional Activity
(A–C) Panels (A)–(C) represent fluorescence images acquired using the same
200 nm section through a pyramidal neuron.
(A) DAPI staining. Scale bar, 1 mm.
(B) Immunostaining with antibodies directed against the phosphorylated CTD
(Ser5) of RNA polymerase II (RNAPII Ser5-P) to detect the active polymerase.
(C) Merged image of DAPI and RNAPII Ser5-P. Note that RNAPII Ser5-P is
excluded from heterochromatic foci.
(D) Total integrated pixel intensity (3105) for RNAPII Ser5-P from WT nuclei
was plotted versus heterochromatin content. RNAPII Ser5-P levels are
negatively correlated with increasing heterochromatin content (n = 51 nuclei
from three mice, Pearson r = 0.72, p < 0.0001).
(E) Scatterplot comparing RNAPII Ser5-P levels in WT and Mecp2-null pyra-
midal neurons. Intensity units represent total integrated pixel intensity (3105)
with mean intensity normalized for WT pyramidal neurons. WT, 27.0 ± 5.0,
n = 51 nuclei from 3 mice; null, 24.5 ± 5.2, n = 55 nuclei from three mice).
Unpaired t test, p = 0.013.analysis of the reconstructed nuclei revealed a strong negative
correlationbetweenPhosphoSer5CTD levels andnuclearhetero-
chromatin content (Figure 6D). We also compared total nuclear
levels of Phospho Ser5 CTD between WT and mutant neurons in
femaleRTThippocampus.Thisanalysis showedaslightbut signif-
icant reduction in Phospho Ser5 CTD in mutant neurons (Fig-
ure 6E). Antibodies against the N terminus of RNAPII did not
work in AT, so we could not determine whether the reduction in
Phospho Ser5 CTD was a result of lower total levels of RNAPII or
is indeed a reflection of reduced transcriptional initiation in
Mecp2-null nuclei. These experiments show that, upon the devel-
opment of improved reagents, AT imaging can be effectively used
to quantify transcriptional activity in different cell types.
DISCUSSION
Here, we describe an adaptation and expansion of AT for the
investigation of chromatin organization. The advantages that252 Cell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc.make AT a useful tool for resolving synaptic junctions in the brain
alsomake it an ideal tool for resolving nuclear compartments. Ul-
trathin sectioning improves resolution along the z axis while also
eliminating signal degradation due to poor depth penetrance of
staining reagents (Micheva and Smith, 2007). We have gener-
ated high-resolution, three-dimensional reconstructions of
nuclei to show how AT can be used to quantify a variety of pa-
rameters of nucleus and chromatin structure.
A powerful feature of AT is the ability to acquiremultiple rounds
of imaging information. This provides a way to survey the molec-
ular composition of specific compartments within the nucleus.
We performed up to five rounds of imaging on one set of serial
sections, but up to nine rounds have been reported with AT (Mi-
cheva and Smith, 2007). Multiplexed immunostaining permits a
candidate screening approach in addition to targeted studies.
In our case, we did not initiate the experiments with a predeter-
mined hypothesis about the spatial organization of H4K20me3
and how loss of MeCP2 may alter this organization. We per-
formed an initial screen of antibodies for histone modifications,
and the results led us to focus onmodifications that mark distinct
heterochromatin territories. For example, H4K20me3- and
H3K27me3-rich regions in WT neurons were adjacent to, but
clearly segregated from, MeCP2-bound heterochromatin (Movie
S3). While we were able to detect the segregated distribution of
H4K20me3 in CA1 pyramidal neurons by conventional confocal
microscopy (Figure S2), AT imaging providedmuch greater reso-
lution of these structures. The importance of examining chro-
matin organization in the brain is underscored by our finding
that dissociated hippocampal neurons did not show distinct
H4K20me3 territories adjacent to pericentromeric heterochro-
matin in culture (J. Sinnamon, personal communication).
By developing FISH conditions for AT, we have added another
dimension to themethod that considerably broadens its applica-
tions. There has recently been great interest in relating spatial or-
ganization of genes with chromatin modifications by combining
HiC analysis with ChIP (Dixon et al., 2012; Rao et al., 2014).
The development of an in situ detectionmethod for chromatin or-
ganization fills a need for investigators who work in systems with
extreme cellular diversity where anatomy is an integral part of the
information desired.
We challenged the AT imaging method by using it on brains
from symptomatic RTT female mice at 4–6 months of age. Not
only does the mammalian brain contain a staggering variety of
cell types, but the mosaic expression of MeCP2 provided a
tightly controlled experimental system for comparing WT and
Mecp2-null cells. Using these methods, AT has provided in vivo
evidence supporting a role for MeCP2 in regulating chromatin ar-
chitecture in neurons. We found that chromatin becomes more
densely packed upon loss of MeCP2. Along with the compac-
tion, we see a dramatic redistribution of H4K20me3 into pericen-
tromeric heterochromatin. Consistent with the finding of more
condensed chromatin, we observed a slight reduction of active
RNAPII in mutant nuclei. The ability to assess large-scale chro-
matin organization, histone modifications, and transcriptional
activity within the same nucleus in its native environment high-
lights the usefulness of AT as tool for chromatin research.
What could explain the increase in chromatin compaction
when MeCP2 is absent in neurons? The redistribution of
H4K20me3 into pericentromeric chromatin accompanied the
increased DNA compaction in Mecp2-null neurons. Given this
result, it is of note that nucleosomal arrays reconstituted with
H4K20me3 modified histones form locally condensed, oligo-
meric structures (Lu et al., 2008). Another potential mechanism
is the interplay between MeCP2 and other chromatin architec-
tural proteins, such as histone H1,whichmay promote higher-or-
der aggregation of chromatin fibers when MeCP2 is absent.
Previous studies have shown that MeCP2 competes with H1
for binding to nucleosomal DNA (Ghosh et al., 2010; Nan et al.,
1997), and levels of H1 increase in the absence ofMeCP2 (Skene
et al., 2010). The presence of other chromatin architectural pro-
teins in nuclei may explain why our results appear to be in oppo-
sition to in vitro studies that show nucleosome compaction in the
presence of purified MeCP2 (Baker et al., 2013; Georgel et al.,
2003). Structural studies need to be performed to compare
how chromatin fibers with repressive histone modifications are
packaged when bound by MeCP2 or H1. Finally, we cannot
exclude the possibility that the chromatin changes are indirect
and downstream effects of gene expression.
We observed similar alterations in chromatin for both hippo-
campal CA1 pyramidal neurons and dentate granule cells, but
we did not detect changes for cerebellar granule cells. This dif-
ference between cell types is consistent with studies showing
that loss of MeCP2 results in different gene expression profiles
depending on neuronal type (Melle´n et al., 2012; Sugino et al.,
2014). It has also been shown that neurons differ with respect
to levels of MeCP2 expression (Chao et al., 2010). Our general
observation is that MeCP2 expression scales with nuclear size,
and cerebellar granule cells express the lowest amount of
MeCP2 of the cell types examined in this study (data not shown).
The lack of changes in H4K20me3 distribution in cerebellar
granule cells agrees with results from a previous study that did
not find differences in histone modifications inMecp2-null retinal
neurons (Song et al., 2014). These results stress the importance
of cell sorting or in situ approaches when studying gene expres-
sion in the brain.
Taken together with previous studies, our AT study suggests
two levels of MeCP2 regulation of gene expression programs.
At one level, MeCP2 prevents higher-order chromatin aggrega-
tion either by preventing H4K20me3 modification or by out-
competing H1 binding at methylated nucleosomal linker DNA.
At another level, MeCP2 functions as a transcriptional regulator,
either through recruitment of co-repressors (Lyst et al., 2013;
Nan et al., 1998) or via recruitment of co-activators (Chahrour
et al., 2008). This second function may be more subject to regu-
lation by signaling pathways, with the phosphorylation state of
MeCP2 dynamically regulating association with its co-factors
(Ebert et al., 2013; Lyst et al., 2013). This dual functionality would
allow MeCP2 to maintain a segregated chromatin fiber that al-
lows for long-lived neurons to adapt their gene expression pro-
grams to events, including synaptic activity or injury. In the
absence of MeCP2, more compact packaging of these se-
quences may restrict such flexibility, and this would agree with
a previous model suggesting that MeCP2 functions as a facili-
tator of transcriptional activation (Melle´n et al., 2012).
The increase in DNA compaction in mutant nuclei raises the
possibility that genes required for neuronal functionmay becomeinappropriately relocated to amore repressive compartment and
thus less subject to regulation by signaling pathways. In future
studies, AT imaging can be combined with emerging FISH stra-
tegies (Beliveau et al., 2015; Boyle et al., 2011) to localize
MeCP2-regulated genes in the RTT brain.
EXPERIMENTAL PROCEDURES
Experimental Animals
Animal procedures were approved by Oregon Health and Science University
Institutional Animal Care and Use Committee regulations and licenses. Mice
were housedwith littermates on a 12:12 hr light/dark cycle. BothMecp2tm3.1Bird
(catalog 014610; Mecp2EGFP; Lyst et al., 2013) and Mecp2tm1.1Bird (catalog
003890;Mecp2Bnull; Guy et al., 2001) mice were obtained from Jackson Labo-
ratory and were maintained on a C57BL/6 background. In order to yield
heterozygote females carrying a germlineMecp2-null mutation and aMecp2-
EGFP allele (Mecp2Bnull/EGFP), Mecp2EGFP/y male mice were crossed to
heterozygous Mecp2Bnull/+ mice. Genotyping for Mecp2Bnull and Mecp2EGFP
alleles were conducted as described previously (Lioy et al., 2011; Lyst et al.,
2013).
Tissue Preparation
The AT procedure was performed using the published protocol with modifi-
cations (Micheva and Smith, 2007). Five-month-old heterozygous RTT fe-
male mice were evaluated for symptoms using the observational scale
(Guy et al., 2007). Mice were anaesthetized by intraperitoneal injection of
Avertin (2,2,2-tribromoethanol) and perfused transcardially with 4% depoly-
merized paraformaldehyde in PBS. The hippocampus was dissected, and sli-
ces of hippocampus were fixed and embedded using microwave irradiation
(PELCO BioWave with ColdSpot; Ted Pella). All sectioning was performed by
the Array Tomography Core at the SOM Beckman Center’s Cell Sciences
Imaging Facility (Jon Mulholland, Director). Serial sections were cut to a
thickness of 200 nm.
Immunofluorescence Procedure
Ribbons of sections were circled with an ImmEdge Pen (Vector Laboratories)
to allow for small staining volumes. The sections were pretreated with 50 mM
glycine in PBS + 0.05% Tween-20, washed with PBS, and blocked with 3%
BSA in PBS (PBS-B) for 15 min prior to application of primary antibodies. Pri-
mary antibodies were incubated with the sections overnight at 4C in PBS-B.
Sections were washed with PBS, and secondary antibodies were incubated
with sections at room temperature for 2 hr in PBS-B. The sections were
washed with PBS and a water rinse before mounting with SlowFade Gold anti-
fade with DAPI (Invitrogen).
To remove bound antibodies prior to a subsequent round of imaging, the rib-
bons were exposed to two rounds of stripping buffer. The first stripping buffer
was 50mMTris (pH 6.8), 2%SDS, 50mMDTT, and the second stripping buffer
was Restore PLUS Western Blot Stripping Buffer (Thermo Scientific). Both
buffers were incubated with sections for 10 min at 42C with very mild agita-
tion. Stripped sections were washed with water and PBS before initiating
another round of immunostaining.
Antibodies
Histone antibodies were prescreened using the Antibody Validation Database
to limit testing to antibodies that have proven specificity records (Egelhofer
et al., 2011). Each antibody was tested independently for AT application,
and we continued to use only those that localized exclusively to the nucleus.
Commercially sourced primary antibodies used in this study include
H4K20me3, clone 6F8-D9 (Abcam, ab78517), H3K9me2 (Abcam, ab1220),
H3K9me3 (Diagenode, mAb-146-050), H3K27me3 (Cell Signaling, #9733),
GFP (Abcam, ab13970), RNA polymerase II clone 4H8 (Abcam, ab5408),
and MAP2 (Abcam, ab5392). Monoclonal antibody specific for H4K20me2
was a gift from Hiroshi Kimura. Secondary antibodies used in this study from
Biotium: CF488A Goat Anti-Mouse IgG2a (20256), CF488A Goat Anti-Chicken
IgY, CF647 Goat Anti-Mouse IgG. Secondary antibodies and lectins used from
Life Technologies: Alexa Fluor 488 conjugated Concanavilin A (C11252), AlexaCell 163, 246–255, September 24, 2015 ª2015 Elsevier Inc. 253
Fluor 555 Goat Anti-Mouse IgG2a (A21137), Alexa Fluor 555 Goat Anti-Rabbit
(A21429), and Alexa Fluor 647 Goat Anti-Chicken (A21449).
Fluorescent In Situ Hybridization
Standard protocols for FISH proved difficult to use with AT due to reduced
adherence of the plastic sections to the coverslip when using formamide
and elevated temperatures. We circumvented this problem by using ethylene
carbonate as a solvent for melting DNA strands for hybridization (Matthiesen
and Hansen, 2012), allowing for lower hybridization temperature. The following
peptide nucleic acid (PNA) probes were used for FISH experiments: Cy3-
labeled PNA probe against minor satellite sequence (CENPB-Cy3) (PNA
Bio). The FITC labeled major satellite PNA probe was a kind gift from Peter
Lansdorp (Falconer et al., 2010). After antibody stripping, the sections were
washed with 1xSSC. Sections were incubated with 0.1 mg/ml pepsin in
10 mM HCl for 2 min at 37C followed by washing with TE, pH 8.8. Sections
were incubated with 200 mg/ml RNase A in 1xSSC for 30 min at 37C and
washed with 1xSSC. The hybridization buffer was similar to the previously
described protocol with some modifications (15% ethylene carbonate, 10%
dextran sulfate, 600 mMNaCl, 10 mM sodium citrate [pH 6.2], 13 Denhardt’s,
and 0.1% Tween-20). After a 30 min prehybridization incubation at 50C, the
sections were incubated with PNA probes for 2 hr at 50C. The samples
were washed with 13 SSC at 50C, with 0.23 SSC at 50C, and rinsed with
water before mounting in SlowFade Gold.
Fluorescence Microscopy and Image Processing
Sections were imaged on a Zeiss Axio Observer.Z1 inverted microscope with
motorized stage. Fluorescence imaging was performed using custom filter
sets and a Lumencor Spectra light engine. Imageswere acquired using a Zeiss
633/1.4 NA Plan Apochromat objective and either AxioCamMRm or Axiocam
506monodigital camera. Image stackswere created in Fiji, and theDAPI image
stacks were aligned using the MultiStackReg plugin. The alignment transform
for the DAPI alignment was applied to image stacks for other fluorescent chan-
nels imaged in the first round. A detailed manual describing the AT alignment
procedure is provided here: http://nisms.stanford.edu/UsingOurServices/
pdf/ArrayTomographyVolumeReconstruction_v1.4.pdf.
Three-Dimensional Analysis
Visualization and quantification of reconstructed nuclei was performed using
Imaris software (Bitplane). A more detailed description of the analysis is
included in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and five movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2015.09.002.
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